4//SEC Filing
Chesworth Richard 4
Accession 0000899243-20-023241
CIK 0001815442other
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 6:28 PM ET
Size
5.5 KB
Accession
0000899243-20-023241
Insider Transaction Report
Form 4
Chesworth Richard
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-08-20+351,119→ 351,119 totalExercise: $20.00Exp: 2030-08-19→ Common Stock (351,119 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on August 17, 2021, and the remainder of the shares shall vest in equal monthly installments for a period of thirty-six (36) months thereafter.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001821188
Filing Metadata
- Form type
- 4
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 6:28 PM ET
- Size
- 5.5 KB